1 |
Li WC, Lee YY, Chen IC, et al. Age and gender differences in the relationship between hepatitis C infection and all stages of chronic kidney disease[J]. J Viral Hepat, 2014,21(10):706-715.
|
2 |
Morrell CN, Aggrey AA, Chapman LM, et al. Emerging roles for platelets as immune and inflammatory cells[J]. Blood,2014,123(18):2759-2767.
|
3 |
Tran TT, Martin P. Chronic hepatitis C[J]. Curr Treat Options Gastroenterol, 2001,4(6): 503-510.
|
4 |
李晶.应用PCR-DNA 探针杂交法检测丙型肝炎核糖核酸[J]. 黑龙江医学,2012,2(36):125-126.
|
5 |
王少敏, 陈杰, 陈早立, 等.丙型肝炎相关自身抗体和血清AST/ALT 比值对丙肝后肝硬化的诊断价值[J]. 实用医学杂志, 2009,25(4):2357-2359.
|
6 |
Puoti C, Castellacci R, Montagnese F. Hepatitis C virus carriers with persistently normal aminotransferase levels: healthy people or true patients? [J]. Dig Liver Dis, 2000,32 (7):634-643.
|
7 |
叶剑荣, 袁利群. 丙型肝炎患者HCVRNA 与转氨酶的关系[J]. 当代医学, 2010,16(12):79-80.
|
8 |
徐潜, 王卫华.综合医院中早期识别与控制丙型病毒性肝炎的探讨[J]. 中华医院感染学杂志, 2011,21(17):3573-3575.
|
9 |
D'Amico G. Renal involvement in Hepatitis C infection:cryoglobulinemic glomerulonephritis [J]. Kidney Int, 1998,54(2) :650-656.
|
10 |
宋磊, 叶明佶, 谢续标, 等.肾损伤标志物表达、作用及不同情况下的变化[J]. 中国组织工程研究, 2012,16(53):10048-10054.
|
11 |
谷茂林. HBV 相关慢性肝炎、肝硬化和肝衰竭患者血清β2-微球蛋白和胱抑素C 联合检测的临床意义[J].临床肝胆病杂志, 2013,29(4):280-285.
|
12 |
柴一红, 李丹帆.肝硬化血小板检测的临床意义[J].临床合理用药,2010,3(24): 64.
|
13 |
唐平, 沈金红. 肝病患者血小板计数及平均血小板体积的变化[J].海军医学杂志, 2006, 27(2):185.
|
14 |
Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets [J]. Nat Rev Microbiol, 2006,4(6):445-457.
|